Disposition and clinical implications of protein-bound uremic toxins

Jitske Jansen, Joachim Jankowski, Prathibha R. Gajjala, Jack F. M. Wetzels, Rosalinde Masereeuw*

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)1631-1647
Number of pages17
JournalClinical Science
Volume131
Issue number14
DOIs
Publication statusPublished - 15 Jul 2017

Keywords

  • CHRONIC KIDNEY-DISEASE
  • P-CRESYL SULFATE
  • ORGANIC ANION TRANSPORTER
  • HUMAN-SERUM-ALBUMIN
  • DRUG-DRUG INTERACTIONS
  • ACUTE-RENAL-FAILURE
  • INDOXYL SULFATE
  • BIOARTIFICIAL KIDNEY
  • GUT MICROBIOME
  • IN-VITRO

Cite this

Jansen, J., Jankowski, J., Gajjala, P. R., Wetzels, J. F. M., & Masereeuw, R. (2017). Disposition and clinical implications of protein-bound uremic toxins. Clinical Science, 131(14), 1631-1647. https://doi.org/10.1042/CS20160191